Yann Mazabraud, EVP, Head of International at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 150,000 shares at $51.72 ($7.7M) on 2025-03-14, disclosed to the SEC on 2025-03-18.
Scheduled sale ($7.7M) by EVP, Head of International under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.79 | 19,197 | $975K | 12.6% |
| 2 | $50.79 | 19,197 | $975K | 12.6% |
| 3 | $51.72 | 55,803 | $2.9M | 37.4% |
| 4 | $51.72 | 55,803 | $2.9M | 37.4% |
| Total | $51.48 avg | 150,000 | $7.7M | 100% |
| Filing → |
| RYTM | SELL | 2025-04-10 | $2.2M | — | Filing → |
| RYTM | SELL | 2024-03-19 | $628K | — | Filing → |
| RYTM | SELL | 2024-02-13 | $211K | — | Filing → |